MedTrace Logo

Dronaderone to Prevent Recurrent Implantable Cardioverter Defibrillator (ICD) Shocks

NCT01430806 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2011-09-08

No results posted yet for this study

Summary

Recurrent ICD shocks are a serious problem in pts with ICD. Treatment failure with other antiarrhythmics and ablation are common. Dronedarone is a new antiarrhythmic drug with ion channel properties similar to amiodarone.

Several case reports have shown promising results with Dronedarone for this patient population.

Conditions

  • ICD
  • ICD SHOCKS
  • DRONEDARONE

Interventions

DRUG

Dronedarone arm

PO Dronedarone 400 mg BID

DRUG

Dronedarone

Dronedarone PO 400 MG BID

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2014-12-31
Completion
2015-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01430806 on ClinicalTrials.gov